Literature DB >> 29239756

Lack of postexposure analgesic efficacy of low concentrations of eugenol in zebrafish.

Bernardo Baldisserotto1, Thaylise V Parodi2, E Don Stevens3.   

Abstract

OBJECTIVE: To test the postexposure analgesic efficacy of low doses of eugenol in zebrafish. STUDY
DESIGN: Prospective experimental study. ANIMALS: A total of 76 large adult zebrafish (Danio rerio).
METHODS: Fish swimming behavior (median velocity, freeze time, high-speed swimming and distance moved in the vertical direction) was recorded in a 1.6 L video arena before and after exposure to eugenol (0, 1, 2, 5, 10 and 20 mg L-1). In a second experiment, fish were anesthetized with 2-phenoxy-ethanol and treated with an injection of 5% acetic acid (noxious stimulus), and then exposed to 0, 1, 2 and 5 mg L-1 eugenol. The fish swimming behavior was also recorded.
RESULTS: The higher doses (10 and 20 mg L-1) reduced the median velocity, high-speed swimming and distance moved in the vertical direction, and increased the freeze time. Zebrafish behavior was not altered by eugenol (1, 2 and 5 mg L-1) after noxious stimulation. CONCLUSIONS AND CLINICAL RELEVANCE: The change in the behavior of zebrafish associated with a noxious stimulus can be monitored and is a good model for studying analgesia in fish. Eugenol (10 and 20 mg L-1) induced zebrafish sedation. The response after a noxious stimulus was not affected by postexposure to lower doses, and thus we cannot recommend its use as an analgesic.
Copyright © 2017 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  fish; noxious stimulus; pain; sedation; swimming behavior

Mesh:

Substances:

Year:  2017        PMID: 29239756     DOI: 10.1016/j.vaa.2017.08.009

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  7 in total

Review 1.  An Overview on the Anti-inflammatory Potential and Antioxidant Profile of Eugenol.

Authors:  Joice Nascimento Barboza; Carlos da Silva Maia Bezerra Filho; Renan Oliveira Silva; Jand Venes R Medeiros; Damião Pergentino de Sousa
Journal:  Oxid Med Cell Longev       Date:  2018-10-22       Impact factor: 6.543

2.  Antioxidant Activities of a New Chemotype of Piper cubeba L. Fruit Essential Oil (Methyleugenol/Eugenol): In Silico Molecular Docking and ADMET Studies.

Authors:  Fahad Alminderej; Sana Bakari; Tariq I Almundarij; Mejdi Snoussi; Kaïss Aouadi; Adel Kadri
Journal:  Plants (Basel)       Date:  2020-11-10

Review 3.  Anticancer Properties of Eugenol: A Review.

Authors:  Ali T Zari; Talal A Zari; Khalid Rehman Hakeem
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

4.  Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.

Authors:  Ahmed K Kammoun; Alaa Khedr; Maha A Hegazy; Ahmed J Almalki; Khaled M Hosny; Walaa A Abualsunun; Samar S A Murshid; Rana B Bakhaidar
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium aromaticum) in FCA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies.

Authors:  Faiyaz Shakeel; Prawez Alam; Abuzer Ali; Mohammed H Alqarni; Abdullah Alshetaili; Mohammed M Ghoneim; Sultan Alshehri; Amena Ali
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

6.  Anesthetic protocol for microinjection-related handling of Siberian sturgeon (Acipenser baerii; Acipenseriformes) prolarvae.

Authors:  Eun Jeong Kim; Yoon Kwon Nam
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

7.  Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea.

Authors:  Adel F Alghaith; Sultan Alshehri; Nabil A Alhakamy; Khaled M Hosny
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.